English   español  

Navegación por Autor Qi, Ming

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 1 a 6 de 6
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
openAccessDaratumumab_Mateos_PV_Art2021.pdf.jpgnov-2021Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONEMateos, Maria Victoria; Dimopoulos, Meletios A.; Cavo, Michele; Suzuki, Kenshi; Knop, Stefan; Doyen, Chantal; Lucio, Paulo; Nagy, Zsolt; Pour, Ludek; Grosicki, Sebastian; Crepaldi, Andre; Liberati, Anna Marina; Campbell, Philip; Yoon, Sung-Soo; Iosava, Genadi; Fujisaki, Tomoaki; Garg, Mamta; Iida, Shinsuke; Bladé, Joan; Ukropec, Jon; Pei, Huiling; Van Rampelbergh, Rian; Kudva, Anupa; Qi, Ming; San-Miguel, Jesúsartículo
openAccessDaratumumab_Moreau_Art_2023.pdf.jpg2023Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUSMoreau, Philippe; Chari, Ajai; Martínez-López, Joaquín; Haenel, Mathias; Touzeau, Cyrille; Ailawadhi, Sikander; Besemer, Britta; Rubia, Javier de la; Encinas, Cristina; Mateos, Maria Victoria; Salwender, Hans; Rodríguez-Otero, Paula; Hulin, Cyrille; Karlin, Lionel; Sureda, Anna; Bargay, Joan; Benboubker, Lotfi; Rosiñol, Laura; Tarantolo, Stefano; Terebelo, Howard; Yang, Shiyi; Wang, Jianping; Nnane, Ivo; Qi, Ming; Kosh, Michele; Delioukina, María; Goldschmidt, Hartmutcarta al director
openAccessExposure-Response_Luo_PV_Art2021.pdf.jpgmay-2021Exposure-Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma PatientsLuo, Man; Usmani, Saad Z.; Mateos, Maria Victoria; Nahi, Hareth; Chari, Ajai; San-Miguel, Jesús; Touzeau, Cyrille; Suzuki, Kenshi; Kaiser, Martin; Carson, Robin; Heuck, Christoph; Qi, Ming; Zhou, Honghui; Sun, Yu-Nien; Parasrampuria, Dolly A.artículo
openAccessFinal analysis of the phase III_Usmani_PV_Art2022.pdf.jpgoct-2022Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myelomaUsmani, Saad Z.; Nahi, Hareth; Legiec, Wojciech; Grosicki, Sebastian; Vorobyev, Vladimir; Špička, Ivan; Hungria, Vania; Korenkova, Sibirina; Bahlis, Nizar J.; Flogegard, Max; Bladé, Joan; Moreau, Philippe; Kaiser, Martin; Iida, Shinsuke; Laubach, Jacob P.; Magen, Hila; Cavo, Michele; Hulin, Cyrille; White, Darrell; Stefano, Valerio De; Lantz, Kristen; O’Rourke, Lisa; Heuck, Christoph; Delioukina, María; Qin, Xiang; Nnane, Ivo; Qi, Ming; Mateos, Maria Victoriaartículo
openAccessInternational_Mateos_Art2020.pdf.jpg2020International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)Mateos, Maria Victoria; Kumar, Sumit; Dimopoulos, Meletios A.; González-Calle, Verónica; Kastritis, Efstathios; Hajek, Roman; Fernández de Larrea, Carlos; Morgan, Gareth J.; Merlini, Giampolo; Goldschmidt, Hartmut; Geraldes, Catarina; Gozzetti, Alessandro; Kyriakou, Charalampia; Garderet, Laurent; Hansson, Markus; Zamagni, Elena; Fantl, Dorotea; Leleu, Xavier; Kim, Byung-Su; Esteves, Graça; Ludwig, Heinz; Usmani, Saad Z.; Min, Chang-Ki; Qi, Ming; Ukropec, Jon; Weiss, Brendan M.; Rajkumar, S. Vincent; Durie, B.; San-Miguel, Jesúsartículo
closedAccessaccesoRestringido.pdf.jpg27-ene-2022Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONESan-Miguel, Jesús; Avet-Loiseau, Hervé; Paiva, Bruno; Kumar, Sumit; Dimopoulos, Meletios A.; Facon, Thierry; Mateos, Maria Victoria; Touzeau, Cyrille; Jakubowiak, Andrzej J.; Usmani, Saad Z.; Cook, Gordon; Cavo, Michele; Quach, Hang; Ukropec, Jon; Ramaswami, Priya; Pei, Huiling; Qi, Mia; Sun, Steven; Wang, Jianping; Krevvata, Maria; DeAngelis, Nikki; Heuck, Christoph; Van Rampelbergh, Rian; Kudva, Anupa; Kobos, Rachel; Qi, Ming; Bahlis, Nizar J.artículo